NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome

by Ed Johnson
November 3, 2021
A A

As an element of Nautilus’ overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam’s antibody development technology and expertise

SEATTLE and CAMBRIDGE, United Kingdom, Nov. 02, 2021 — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a strategic development and supply partnership.

The relationship leverages Abcam’s industry-leading recombinant monoclonal antibody development technologies and expertise to enhance Nautilus’ reagent research and development, and establishes a long-term supply relationship between the companies. The partnership will initially focus on the collaborative development of affinity binding reagents for use on the Nautilus proteomic analysis system, and will expand in the near future to the large-scale manufacture and supply of reagents for commercialization.

“We are excited to be working closely with Abcam to build reagents that we believe will further enhance our proteomic analysis methods,” said Sujal Patel, co-founder and CEO of Nautilus Biotechnology. “They, like us, envision a future in which proteomic data is expected to become an increasingly important resource that has the potential to support the creation of more effective drugs and diagnostics. Our ability to partner with a company as respected and successful as Abcam provides a strong vote of confidence in that future, and in the promise of the Nautilus protein analysis platform to help make it a reality.”

Abcam’s scale and recombinant antibody manufacturing expertise is expected to support Nautilus in meeting its long-term reagent supply needs from research and development through to commercialization.

“The prospect of biomedical researchers being able to interrogate the proteome at a more comprehensive level offers exciting possibilities for discovery and innovation across multiple disease areas,” said Alan Hirzel, CEO of Abcam. “By combining Nautilus’ protein analysis platform and Abcam’s antibody discovery, development and manufacturing expertise, we hope to better support scientists in the development of drugs and diagnostic tools that ultimately improve outcomes for patients.”

Under the terms of the agreement, Abcam will provide Nautilus with antibodies that are expected to add to and enhance its own library of affinity binding reagents, highlighting the open and customizable nature of Nautilus’ technology. With simple labeling chemistry, the Nautilus platform is designed for use with virtually any biological reagent.

Tags: < Partnership
ShareTweetShareSend

Related Industries

Healthcare

Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report

May 18, 2023
Healthcare

Oncotelic Participating at 2023 BIO International Convention

May 17, 2023
Healthcare

Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution

May 17, 2023
Healthcare

Amgen Responds to Ftc Action RE: Proposed Acquisition Of Horizon Therapeutics

May 17, 2023
Healthcare

Cardinal Health Canada to open new distribution center in Ontario

May 11, 2023
Healthcare

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next Generation Sequencing-Based Testing for Cancer Patients in International Markets

May 10, 2023

Apple’s Worldwide Developers Conference to kick off June 5, 2023, with keynote address

May 24, 2023

...

Alstom and EDC enter into a strategic partnership for sustainable mobility financing

May 17, 2023

...

DuPont Earns Great Place to Work Certification™

May 18, 2023

...

PPG Board of Directors recognized as ‘Public Company Board of the Year’

May 13, 2023

...

Dow’s Seadrift, Texas location selected for X-energy advanced SMR nuclear project to deliver safe, reliable, zero carbon emissions power and steam production

May 12, 2023

...

Rockwell Automation and Avid Solutions Partner to Accelerate and Scale Green Hydrogen Production

May 18, 2023

...

Jeanine Wai is appointed Vice President, Investor Relations North America of TotalEnergies

June 2, 2023

...

Rockwell Automation Names Matt Fordenwalt Senior Vice President, Lifecycle Services

May 26, 2023

...

Legacy Corporate Lending, New Asset-based Lending Company, Launches With Investment From Bain Capital Credit

May 10, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.